{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T05:06:10Z","timestamp":1779512770143,"version":"3.53.1"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007623","name":"School of Medicine, Emory University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007623","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.coi.2026.102755","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T19:59:29Z","timestamp":1773691169000},"page":"102755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mpox emergence and new vaccines: a story of susceptibility"],"prefix":"10.1016","volume":"100","author":[{"given":"Samuel D","family":"Stampfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra W","family":"Dretler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6309-6797","authenticated-orcid":false,"given":"Rama R","family":"Amara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2026.102755_bib1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1699-0463.1959.tb00328.x","article-title":"A pox-like disease in cynomolgus monkeys","volume":"46","author":"von Magnus","year":"1959","journal-title":"Acta Pathol Microbiol Scand"},{"key":"10.1016\/j.coi.2026.102755_bib2","first-page":"569","article-title":"Human monkeypox","volume":"46","author":"Foster","year":"1972","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.coi.2026.102755_sbref3","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3201\/eid3108.241551","article-title":"Emergence of clade Ib monkeypox virus-current state of evidence","volume":"31","author":"Satheshkumar","year":"2025","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coi.2026.102755_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010384","article-title":"Clinical characterization and placental pathology of mpox infection in hospitalized patients in the Democratic Republic of the Congo","volume":"17","author":"Pittman","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coi.2026.102755_bib5","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMoa2215201","article-title":"Vaccine effectiveness of JYNNEOS against Mpox disease in the United States","volume":"388","author":"Deputy","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2026.102755_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/v15030727","article-title":"Identifying the most probable mammal reservoir hosts for monkeypox virus based on ecological niche comparisons","volume":"15","author":"Curaudeau","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.coi.2026.102755_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2022.101004","article-title":"Monkeypox virus outbreak: a brief timeline","volume":"48","author":"Anwar","year":"2022","journal-title":"New Microbes New Infect"},{"key":"10.1016\/j.coi.2026.102755_bib8","first-page":"5624","article-title":"Human monkeypox outbreak: global prevalence and biological, epidemiological and clinical characteristics \u2013 observational analysis between 1970-2022","volume":"26","author":"Meo","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.coi.2026.102755_bib9","unstructured":"Global Mpox Trends. Edited by WHO. \u3008https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/\u3009; 2\/06\/2026."},{"key":"10.1016\/j.coi.2026.102755_bib10","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/jdv.19223","article-title":"Characteristics of mpox positive, versus mpox negative, and mpox unsuspected clients from the Centre of Sexual Health, Public Health Service of Amsterdam, 20 May to 15 September 2022","volume":"37","author":"van Heukelom","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.coi.2026.102755_sbref10","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.1093\/infdis\/jiad505","article-title":"Associations between HIV and severe mpox in an Atlanta cohort","volume":"229","author":"Aldred","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2026.102755_bib12","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1038\/s41591-024-03130-3","article-title":"Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo","volume":"30","author":"Vakaniaki","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102755_bib13","unstructured":"Clade I Monkeypox Outbreak Originating in Central Africa. Edited by CDC. \u3008https:\/\/www.cdc.gov\/monkeypox\/outbreaks\/2023\/index.html\u3009; 10\/15\/2025."},{"key":"10.1016\/j.coi.2026.102755_bib14","unstructured":"Africa CDC Epidemic Intelligence Weekly Report; October 2025. Edited by AfricaCDC. \u3008https:\/\/africacdc.org\/download\/africa-cdc-epidemic-intelligence-weekly-report-october-2025\/\u3009."},{"key":"10.1016\/j.coi.2026.102755_bib15","unstructured":"Community Spread of Clade I Mpox Within California. Edited by California Department of Public Health."},{"key":"10.1016\/j.coi.2026.102755_bib16","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","article-title":"Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus","volume":"28","author":"Isidro","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102755_bib17","article-title":"Genomic annotation and molecular evolution of monkeypox virus outbreak in 2022","volume":"95","author":"Wang","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.coi.2026.102755_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2456144","article-title":"A functional approach to analyze the genetic basis for differences in virulence of monkeypox virus clades","volume":"14","author":"Earl","year":"2025","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.coi.2026.102755_sbref15","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101098","article-title":"The impact of orthopoxvirus vaccination and mpox infection on cross-protective immunity: a multicohort observational study","volume":"6","author":"Crandell","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.coi.2026.102755_sbref16","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S1473-3099(22)00664-8","article-title":"The global landscape of smallpox vaccination history and implications for current and future orthopoxvirus susceptibility: a modelling study","volume":"23","author":"Taube","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2026.102755_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103526","article-title":"Global transmission characteristics of mpox outbreaks: a systematic review and meta-analysis","volume":"89","author":"Wu","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.coi.2026.102755_bib22","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.3201\/eid3010.240665","article-title":"Epidemiologic quantities for monkeypox virus clade I from historical data with implications for current outbreaks, Democratic Republic of the Congo","volume":"30","author":"Marziano","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coi.2026.102755_bib23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","article-title":"A prospective study of serum antibody and protection against smallpox","volume":"21","author":"Mack","year":"1972","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coi.2026.102755_bib24","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102755_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.virol.2007.04.010","article-title":"DNA\/MVA HIV-1\/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge","volume":"366","author":"Nigam","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.coi.2026.102755_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.virol.2007.02.041","article-title":"Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate","volume":"366","author":"Earl","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.coi.2026.102755_bib27","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1093\/infdis\/jiad532","article-title":"Prolonged mpox disease in people with advanced HIV: characterization of mpox skin lesions","volume":"229","author":"O'Shea","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2026.102755_bib28","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.4049\/jimmunol.1400256","article-title":"CD8 T cells use IFN-gamma to protect against the lethal effects of a respiratory poxvirus infection","volume":"192","author":"Goulding","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2026.102755_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1473-3099(23)00492-9","article-title":"Mpox in people with past infection or a complete vaccination course: a global case series","volume":"24","author":"Hazra","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2026.102755_bib30","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S1473-3099(23)00352-3","article-title":"Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study","volume":"23","author":"Cohn","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2026.102755_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116501","article-title":"Mpox-specific cellular and humoral immunity in mpox survivors living with HIV","volume":"44","author":"Stampfer","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2026.102755_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.coi.2026.102755_bib33","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.vaccine.2009.09.133","article-title":"Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates","volume":"28","author":"Hooper","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2026.102755_bib34","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2026.102755_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-025-01193-y","article-title":"A new attenuated and highly immunogenic orthopoxvirus vaccine protects against mpox in mice and macaques","volume":"10","author":"Xu","year":"2025","journal-title":"NPJ Vaccin"},{"key":"10.1016\/j.coi.2026.102755_sbref32","article-title":"Tiantan vaccinia virus-based vaccine with promising safety provides sustained protection against mpox in non-human primates","volume":"16","author":"Zhu","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102755_sbref33","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1038\/s41467-025-59826-8","article-title":"Mpox multiprotein virus-like nanoparticle vaccine induces neutralizing and protective antibodies in mice and non-human primates","volume":"16","author":"Belghith","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102755_bib38","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2535485","article-title":"A bivalent mpox nanoparticle vaccine induces robust immune response and provides long-lasting protection against vaccinia virus challenge","volume":"14","author":"Wang","year":"2025","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.coi.2026.102755_sbref35","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2482702","article-title":"Rational mpox vaccine design: immunogenicity and protective effect of individual and multicomponent proteins in mice","volume":"14","author":"Cheng","year":"2025","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.coi.2026.102755_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105392","article-title":"Single-chain A35R-M1R-B6R trivalent mRNA vaccines protect mice against both mpox virus and vaccinia virus","volume":"109","author":"Kong","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coi.2026.102755_sbref37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54909-4","article-title":"A penta-component mpox mRNA vaccine induces protective immunity in nonhuman primates","volume":"15","author":"Ye","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102755_bib42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.15585\/mmwr.mm7220a4","article-title":"Effectiveness of JYNNEOS vaccine against diagnosed mpox infection \u2013 New York, 2022","volume":"72","author":"Rosenberg","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coi.2026.102755_sbref39","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.06.021","article-title":"Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: a systematic review and meta-analysis","volume":"42","author":"Pischel","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2026.102755_bib44","unstructured":"Interim Clinical Considerations for Use of Vaccine for Monkeypox Prevention in the United States. Edited by CDC; 9\/5\/2025."},{"key":"10.1016\/j.coi.2026.102755_bib45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-022-02090-w","article-title":"Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals","volume":"29","author":"Zaeck","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102755_bib46","article-title":"The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody response","volume":"99","author":"Oom","year":"2025","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2026.102755_bib47","series-title":"An Inquiry Into the Causes and Effects of the Variolae Vaccinae, 1798","author":"Jenner","year":"1798"},{"key":"10.1016\/j.coi.2026.102755_bib48","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1128\/JVI.78.8.3811-3816.2004","article-title":"Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells","volume":"78","author":"Amara","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2026.102755_bib49","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102755_bib50","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2026.102755_bib51","doi-asserted-by":"crossref","first-page":"7323","DOI":"10.1016\/j.vaccine.2020.09.037","article-title":"Prospective safety surveillance study of ACAM2000 smallpox vaccine in deploying military personnel","volume":"38","author":"Faix","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2026.102755_bib52","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/v15020356","article-title":"Single dose of recombinant chimeric horsepox virus (TNX-801) vaccination protects macaques from lethal monkeypox challenge","volume":"15","author":"Noyce","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.coi.2026.102755_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00265-24","article-title":"Recombinant chimeric horsepox virus (TNX-801) is attenuated relative to vaccinia virus strains in both in vitro and in vivo models","volume":"9","author":"Trefry","year":"2024","journal-title":"mSphere"},{"key":"10.1016\/j.coi.2026.102755_bib54","first-page":"394","article-title":"Genome stability of the vaccine strain VACDelta6","volume":"26","author":"Maksyutov","year":"2022","journal-title":"Vavilovskii Zhurnal Genet Sel"},{"key":"10.1016\/j.coi.2026.102755_bib55","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/v15010103","article-title":"Smallpox, monkeypox and other human orthopoxvirus infections","volume":"15","author":"Shchelkunova","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.coi.2026.102755_bib56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3121\/cmr.1.2.87","article-title":"Smallpox vaccine: the good, the bad, and the ugly","volume":"1","author":"Belongia","year":"2003","journal-title":"Clin Med Res"},{"key":"10.1016\/j.coi.2026.102755_sbref52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114339","article-title":"A multivalent nanoparticle vaccine elicits potent neutralizing antibody response against monkeypox virus","volume":"388","author":"Yuan","year":"2025","journal-title":"J Control Release"},{"key":"10.1016\/j.coi.2026.102755_bib58","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/v4050688","article-title":"Poxvirus cell entry: how many proteins does it take?","volume":"4","author":"Moss","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.coi.2026.102755_bib59","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.3390\/v15122396","article-title":"Neutralization determinants on poxviruses","volume":"15","author":"Riccardo","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.coi.2026.102755_bib60","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1073\/pnas.0601025103","article-title":"Ligand-induced and nonfusogenic dissolution of a viral membrane","volume":"103","author":"Law","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2026.102755_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-06990-2","article-title":"Monkeypox virus protein H3L induces injuries in human and mouse","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.coi.2026.102755_sbref57","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1016\/j.cell.2024.08.043","article-title":"Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates","volume":"187","author":"Mucker","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.coi.2026.102755_sbref58","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","article-title":"A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease","volume":"187","author":"Zuiani","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.coi.2026.102755_bib64","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41422-023-00792-5","article-title":"Polyvalent mRNA vaccination elicited potent immune response to monkeypox virus surface antigens","volume":"33","author":"Fang","year":"2023","journal-title":"Cell Res"},{"key":"10.1016\/j.coi.2026.102755_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105974","article-title":"An mpox quadrivalent mRNA vaccine protects mice from lethal vaccinia virus challenge","volume":"230","author":"Li","year":"2024","journal-title":"Antivir Res"},{"key":"10.1016\/j.coi.2026.102755_bib66","article-title":"Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus","volume":"8","author":"Sang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.coi.2026.102755_bib67","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/vaccines13050514","article-title":"A Single-chain mpox mRNA vaccine elicits protective immune response in mice","volume":"13","author":"Xu","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2026.102755_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114269","article-title":"Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus","volume":"43","author":"Ye","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2026.102755_bib69","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2204151","article-title":"Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge","volume":"12","author":"Zeng","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.coi.2026.102755_bib70","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/vaccines13040374","article-title":"An mpox multi-antigen-tandem bivalent mRNA candidate vaccine effectively protects mice against the vaccinia virus","volume":"13","author":"Zuo","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2026.102755_bib71","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/vaccines12070776","article-title":"Enhanced immune responses in mice by combining the mpox virus B6R-protein and aluminum hydroxide-CpG vaccine adjuvants","volume":"12","author":"Li","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2026.102755_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1203410","article-title":"Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge","volume":"14","author":"Tang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102755_bib73","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/cb600489g","article-title":"Activating B cell signaling with defined multivalent ligands","volume":"2","author":"Puffer","year":"2007","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.coi.2026.102755_bib74","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2384189","article-title":"Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine","volume":"20","author":"Greenberg","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.coi.2026.102755_bib75","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJMoa2412439","article-title":"Tecovirimat for clade I MPXV infection in the Democratic Republic of Congo","volume":"392","author":"Group","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2026.102755_bib76","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/COH.0000000000001014","article-title":"Monoclonal antibodies for Mpox: protective targets and therapeutic potential","volume":"21","author":"Guardado-Calvo","year":"2026","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.coi.2026.102755_bib77","doi-asserted-by":"crossref","first-page":"460","DOI":"10.15585\/mmwr.mm7320a3","article-title":"Monkeypox virus infections after 2 preexposure doses of JYNNEOS vaccine \u2013 United States, May 2022\u2013May 2024","volume":"73","author":"Guagliardo","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coi.2026.102755_bib78","doi-asserted-by":"crossref","first-page":"385","DOI":"10.15585\/mmwr.mm7422a3","article-title":"Use of JYNNEOS (smallpox and mpox vaccine, live, nonreplicating) for persons aged >\/=18 years at risk for mpox during an mpox outbreak: recommendations of the Advisory Committee on Immunization Practices \u2013 United States, 2023","volume":"74","author":"Rao","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coi.2026.102755_bib79","doi-asserted-by":"crossref","first-page":"553","DOI":"10.15585\/mmwr.mm7220a3","article-title":"Estimated effectiveness of JYNNEOS vaccine in preventing mpox: a multijurisdictional case-control study \u2013 United States, August 19, 2022\u2013March 31, 2023","volume":"72","author":"Dalton","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coi.2026.102755_bib80","doi-asserted-by":"crossref","first-page":"11873","DOI":"10.1128\/JVI.79.18.11873-11891.2005","article-title":"An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection","volume":"79","author":"Morikawa","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2026.102755_bib81","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300290","article-title":"Mpox neutralizing antibody response to LC16m8 vaccine in healthy adults","volume":"3","author":"Morino","year":"2024","journal-title":"NEJM Evid"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:20:45Z","timestamp":1779510045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791526000324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":81,"alternative-id":["S0952791526000324"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2026.102755","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mpox emergence and new vaccines: a story of susceptibility","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2026.102755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102755"}}